Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus‐associated head and neck cancer based on a prospective clinical experience
- 20 April 2010
- Vol. 116 (9), 2166-2173
- https://doi.org/10.1002/cncr.25033
Abstract
BACKGROUND: Human papillomavirus (HPV) is a causative agent in a subset of head and neck squamous cell carcinomas (HNSCCs). These HPV‐related cancers have a clinicopathologic profile that diverges from HPV‐negative HNSCCs. Accordingly, HPV testing may soon become integrated into standard pathologic assessment of HNSCCs. METHODS: Data were prospectively collected for all patients with head and neck carcinomas who had undergone HPV testing at the Johns Hopkins Hospital as part of clinical care during a 57‐month period. HPV testing consisted of concurrent HPV16 in situ hybridization (ISH) and p16 immunohistochemistry (IHC). Wide spectrum HPV ISH was reserved for p16‐positive cases that were HPV‐16 negative. RESULTS: HPV analysis was performed on 256 head and neck carcinomas in an effort to predict clinical outcomes (56%), localize primary tumor origin (21%), establish tumor classification (9%), determine patient eligibility for vaccine trials (8%), or satisfy patient curiosity (5%). A total of 182 (71%) tumors were HPV positive. HPV positivity correlated with oropharyngeal site (82% vs 9%) and male sex (77% vs 48%). p16 positivity was present in all 176 HPV16‐positive cases, and in 19 of 80 (24%) cases that were HPV‐16 negative. In 6 (32%) discordant cases, p16 expression was because of the presence of another HPV type. CONCLUSIONS A feasible strategy that incorporates p16 IHC and HPV ISH is able to detect HPV in a high percentage of oropharyngeal carcinomas. HPV status is frequently requested by the oncologist to estimate clinical outcome, and used by pathologists to establish tumor classification and determine site of tumor origin. Cancer 2010. © 2010 American Cancer Society.This publication has 25 references indexed in Scilit:
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI Journal of the National Cancer Institute, 2008
- Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma VirusThe Laryngoscope, 2007
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 2007
- Case–Control Study of Human Papillomavirus and Oropharyngeal CancerThe New England Journal of Medicine, 2007
- Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable PrognosisJournal of Clinical Oncology, 2006
- Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar CarcinomaClinical Cancer Research, 2005
- Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entitySeminars in Oncology, 2004
- Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancersInternational Journal of Cancer, 2003
- Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck CancersJNCI Journal of the National Cancer Institute, 2000
- Human papillomavirus (HPV) in head and neck cancerCancer, 1997